Top Markets
#1 Ontology Gas Ontology Gas +45.91%
#2 Verus Coin Verus Coin +22.51%
#3 EXOD EXOD +22.08%
#4 Status Status +19.78%
#5 ETHGas ETHGas +18.84%
#6 Geodnet Geodnet +16.73%
#7 The Black Bull The Black Bull +16.27%
#8 Derive Derive +11.24%
#9 Fake World Assets Fake World Assets +11.05%
#10 Gas Gas +9.27%
Coin of the day
Ontology Gas Ontology Gas
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Rankning i aktier #25521
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Aktiekurs
$9.81
Senast synkroniserad: 2025-03-18
Marknadsvärde
$48.68M
Förändring (1 dag)
1.55%
Förändring (1 år)
0.00%
Land
US
Handel AlloVir, Inc. (ALVR)

Kategori

Healthcare
Utdelningsavkastning för AlloVir, Inc. (ALVR)
Utdelningsavkastningen (TTM) för AlloVir, Inc. (aktiesymbol: ALVR) per 2023-12-31 är: 0.00%
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för AlloVir, Inc. (ALVR) från 2022 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter
Företag Utdelningsavkastning Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US